Commentary on the respiratory infection risk in primary Sj ögren’s syndrome complicated with interstitial lung disease
(Source: Clinical Rheumatology)
Source: Clinical Rheumatology - March 26, 2024 Category: Rheumatology Source Type: research
Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes
CONCLUSIONS: Anti-Ro52+ antibody alone is frequently found in patients with non-rheumatic diseases. In addition, anti-Ro52+ antibody is also prevalent in patients with CTD and associated with clinical phenotypes that are different from anti-Ro60+ antibody.PMID:38530658 | DOI:10.55563/clinexprheumatol/puxml7 (Source: Clinical and Experimental Rheumatology)
Source: Clinical and Experimental Rheumatology - March 26, 2024 Category: Rheumatology Authors: Carolina Mazeda Natacha Oliveira Catarina Abreu Vanessa Fraga Isabel Maduro Andr é Saraiva Lu ís Inês Carla Ferreira Ana Margarida Correia Rafaela Nicolau Filipa Farinha Ingrid Villanueva Diogo Jesus Pedro Abreu Agna Neto Joana Silva Dinis Anabela Barc Source Type: research
Pulmonary Manifestations of Connective Tissue Diseases
Semin Respir Crit Care Med. 2024 Mar 26. doi: 10.1055/s-0044-1782607. Online ahead of print.ABSTRACTSystemic sclerosis is a multisystem connective tissue disease that is associated with substantial morbidity and mortality. Visceral organ involvement is common in patients with systemic sclerosis and occurs independently of skin manifestations. Pulmonary hypertension (PH) is an important and prevalent complication of systemic sclerosis. The clinical classification of PH cohorts conditions with similar pathophysiological mechanisms into one of five groups. While patients with systemic sclerosis can manifest with a spectrum of...
Source: Respiratory Care - March 26, 2024 Category: Respiratory Medicine Authors: Sarah Cullivan Eleanor Cronin Sean Gaine Source Type: research
Anti-SSA Ro52 and anti-Ro60 autoantibodies: association with clinical phenotypes
CONCLUSIONS: Anti-Ro52+ antibody alone is frequently found in patients with non-rheumatic diseases. In addition, anti-Ro52+ antibody is also prevalent in patients with CTD and associated with clinical phenotypes that are different from anti-Ro60+ antibody.PMID:38530658 | DOI:10.55563/clinexprheumatol/puxml7 (Source: Clinical and Experimental Rheumatology)
Source: Clinical and Experimental Rheumatology - March 26, 2024 Category: Rheumatology Authors: Carolina Mazeda Natacha Oliveira Catarina Abreu Vanessa Fraga Isabel Maduro Andr é Saraiva Lu ís Inês Carla Ferreira Ana Margarida Correia Rafaela Nicolau Filipa Farinha Ingrid Villanueva Diogo Jesus Pedro Abreu Agna Neto Joana Silva Dinis Anabela Barc Source Type: research
Pulmonary Manifestations of Connective Tissue Diseases
Semin Respir Crit Care Med DOI: 10.1055/s-0044-1782607Systemic sclerosis is a multisystem connective tissue disease that is associated with substantial morbidity and mortality. Visceral organ involvement is common in patients with systemic sclerosis and occurs independently of skin manifestations. Pulmonary hypertension (PH) is an important and prevalent complication of systemic sclerosis. The clinical classification of PH cohorts conditions with similar pathophysiological mechanisms into one of five groups. While patients with systemic sclerosis can manifest with a spectrum of pulmonary vascular disease, notable clinical ...
Source: Seminars in Respiratory and Critical Care Medicine - March 26, 2024 Category: Respiratory Medicine Authors: Cullivan, Sarah Cronin, Eleanor Gaine, Sean Tags: Review Article Source Type: research
Successful thoracoscopic operative approach for refractory pneumothorax in interstitial lung disease under local anaesthesia
We report the case of a 60-year-old man with ILD, utilizing home oxygen therapy, who experienced a successful recovery from a surgical intervention under local anaesthesia for pneumothorax. AbstractRefractory pneumothorax associated with interstitial lung disease (ILD) remains a challenging condition due to the patient's tolerability and lung compliance that restrict the feasibility of aggressive interventions. Additionally, many cases recur after improvement with treatment, and reports of successful management for this complicated condition are limited. Herein, we report the case of a 60-year-old man with ILD, utilizing h...
Source: Respirology Case Reports - March 25, 2024 Category: Respiratory Medicine Authors: Shinya Yamanaka,
Clara So,
Naoki Nishimura,
Tomoaki Nakamura,
Shinsaku Kabemura,
Ryosuke Kumagai,
Kohei Okafuji,
Atsushi Kitamura,
Fumitsugu Kojima,
Yutaka Tomishima,
Torahiko Jinta,
Toru Bando Tags: CASE REPORT Source Type: research
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
CONCLUSION: Both physical and mental health are significantly impaired in IIM patients, particularly in those with comorbidities and increased fatigue, emphasizing the importance of patient-reported experiences and optimized multidisciplinary care to enhance well-being in people with IIMs.PMID:38524696 | PMC:PMC10960935 | DOI:10.1093/rap/rkae028 (Source: Adv Data)
Source: Adv Data - March 25, 2024 Category: Epidemiology Authors: Akira Yoshida Yuan Li Vahed Maroufy Masataka Kuwana Syahrul Sazliyana Shaharir Ashima Makol Parikshit Sen James B Lilleker Vishwesh Agarwal Esha Kadam Phonpen Akawatcharangura Goo Jessica Day Marcin Milchert Yi-Ming Chen Dzifa Dey Tsvetelina Velikova Sreo Source Type: research
Impaired health-related quality of life in idiopathic inflammatory myopathies: a cross-sectional analysis from the COVAD-2 e-survey
CONCLUSION: Both physical and mental health are significantly impaired in IIM patients, particularly in those with comorbidities and increased fatigue, emphasizing the importance of patient-reported experiences and optimized multidisciplinary care to enhance well-being in people with IIMs.PMID:38524696 | PMC:PMC10960935 | DOI:10.1093/rap/rkae028 (Source: Adv Data)
Source: Adv Data - March 25, 2024 Category: Epidemiology Authors: Akira Yoshida Yuan Li Vahed Maroufy Masataka Kuwana Syahrul Sazliyana Shaharir Ashima Makol Parikshit Sen James B Lilleker Vishwesh Agarwal Esha Kadam Phonpen Akawatcharangura Goo Jessica Day Marcin Milchert Yi-Ming Chen Dzifa Dey Tsvetelina Velikova Sreo Source Type: research
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
In conclusion, nivolumab showed a similar safety profile and comparable effectiveness to that reported in clinical trials for relapsed/refractory cHL (CheckMate 205, ONO-4538-15).PMID:38521840 | DOI:10.1007/s12185-024-03734-y (Source: International Journal of Hematology)
Source: International Journal of Hematology - March 24, 2024 Category: Hematology Authors: Akira Kawasaki Kiyohiko Hatake Itaru Matsumura Koji Izutsu Tomohiro Hoshino Ayumi Akamatsu Akito Kakuuchi Kensei Tobinai Source Type: research
Secondary Pulmonary Alveolar Proteinosis Development during the Treatment for Anti-aminoacyl-tRNA Synthetase Antibody-positive Interstitial Lung Disease
Intern Med. 2024 Mar 25. doi: 10.2169/internalmedicine.3327-23. Online ahead of print.ABSTRACTA 70-year-old woman with anti-aminoacyl-tRNA synthetase (ARS) antibody-positive interstitial lung disease (ARS-ILD) received daily medications and regular cyclophosphamide cycles for recurring exacerbations. Approximately four years after immunosuppression initiation, the patient was admitted for progressive dyspnea on exertion. Chest computed tomography (CT) findings were suggestive of acute exacerbation. Despite intensified immunosuppressive treatment, the radiographic findings worsened, and serum Krebs von den Lungen-6 (KL-6) l...
Source: Internal Medicine - March 24, 2024 Category: Internal Medicine Authors: Suzuka Matsuoka Keiichi Fujiwara Yuki Takigawa Saki Ito Sho Mitsumune Keisuke Shiraha Mayu Goda Tomoyoshi Inoue Miho Fujiwara Eri Nakamura Hiromi Watanabe Kenichiro Kudo Akiko Sato Ken Sato Takuo Shibayama Source Type: research
Post-marketing surveillance of the safety and effectiveness of nivolumab for classic Hodgkin lymphoma in Japan
In conclusion, nivolumab showed a similar safety profile and comparable effectiveness to that reported in clinical trials for relapsed/refractory cHL (CheckMate 205, ONO-4538-15).PMID:38521840 | DOI:10.1007/s12185-024-03734-y (Source: International Journal of Hematology)
Source: International Journal of Hematology - March 24, 2024 Category: Hematology Authors: Akira Kawasaki Kiyohiko Hatake Itaru Matsumura Koji Izutsu Tomohiro Hoshino Ayumi Akamatsu Akito Kakuuchi Kensei Tobinai Source Type: research
Secondary Pulmonary Alveolar Proteinosis Development during the Treatment for Anti-aminoacyl-tRNA Synthetase Antibody-positive Interstitial Lung Disease
Intern Med. 2024 Mar 25. doi: 10.2169/internalmedicine.3327-23. Online ahead of print.ABSTRACTA 70-year-old woman with anti-aminoacyl-tRNA synthetase (ARS) antibody-positive interstitial lung disease (ARS-ILD) received daily medications and regular cyclophosphamide cycles for recurring exacerbations. Approximately four years after immunosuppression initiation, the patient was admitted for progressive dyspnea on exertion. Chest computed tomography (CT) findings were suggestive of acute exacerbation. Despite intensified immunosuppressive treatment, the radiographic findings worsened, and serum Krebs von den Lungen-6 (KL-6) l...
Source: Internal Medicine - March 24, 2024 Category: Internal Medicine Authors: Suzuka Matsuoka Keiichi Fujiwara Yuki Takigawa Saki Ito Sho Mitsumune Keisuke Shiraha Mayu Goda Tomoyoshi Inoue Miho Fujiwara Eri Nakamura Hiromi Watanabe Kenichiro Kudo Akiko Sato Ken Sato Takuo Shibayama Source Type: research
